A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

8.5K views

DOI:

10.3791/56325

October 12th, 2017

In This Article

Summary

We describe here a fluorometric cell-free biochemical assay for determination of HDL-lipid peroxidation. This rapid and reproducible assay can be used to determine HDL function in large scale studies and can contribute to our understanding of HDL function in human disease.

Abstract

Low high-density lipoprotein cholesterol (HDL-C) levels are one of the most powerful independent negative predictors of atherosclerotic cardiovascular disease (CVD). The structure and function of HDL rather than HDL-C may more accurately predict atherosclerosis. Several HDL protein and lipid compositional changes that impair HDL function occur in inflammatory states such as atherosclerosis. HDL function is usually determined by cell based assays such as cholesterol efflux assay but these assays have numerous drawbacks lack of standardization. Cell-free assays may give more robust measures of HDL function compared to cell-based assays. HDL oxidation impairs HDL function. HDL has a major role in lipid peroxide transport and high amount of lipid peroxides is related to abnormal HDL function. Lipid-probe interactions should be considered when interpreting the results of non-enzymatic fluorescence assays for measuring the lipid oxidative state. This motivated us to develop a cell-free biochemical enzymatic method to assess HDL lipid peroxide content (HDLox) that contributes to HDL dysfunction. This method is based on the enzyme horseradish peroxidase (HRP) and the fluorochrome Amplex Red that can quantify (without cholesterol oxidase) the lipid peroxide content per mg of HDL-C. Here a protocol is describedfor determination of HDL-lipid peroxidation using the fluorochrome reagent. Assay variability can be reduced by strict standardization of experimental conditions. Higher HDLox values are associated with reduced HDL antioxidant function. The readout of this assay is associated with readouts of validated cell-based assays, surrogate measures of cardiovascular disease, systemic inflammation, immune dysfunction, and associated cardiovascular and metabolic risk phenotypes. This technical approach is a robust method to assess HDL function in human disease where systemic inflammation, oxidative stress and oxidized lipids have a key role (such as atherosclerosis).

Introduction

Atherosclerotic cardiovascular disease (CVD) is the leading cause of death worldwide1,2. Epidemiological studies have shown that low levels of high-density lipoprotein (HDL) cholesterol are generally inversely associated with the risk for the development of atherosclerosis1,2. Although several studies support an atheroprotective role for HDL1,2, the mechanism by which HDL attenuates the initiation and progression of atherosclerosis is complex 3,

Access restricted. Please log in or start a trial to view this content.

Protocol

All experiments using human biological samples were performed with ethics approval from the University of California Los Angeles, Los Angeles and the Alfred Hospital Human Ethics committee, Melbourne.

NOTE: There are many variations of the fluorochrome HDL function Assay (see discussion)32. Below we will describe the protocol that gives the most consistent and reproducible results. An overview of the assay is shown in Figure 2.

1. Specimen Processing

  1. Use fresh, non-hemolyzed serum (can be collected in serum separator tubes) or citrate plasma obtain....

Access restricted. Please log in or start a trial to view this content.

Results

50 µL of each HDL sample are added into each well as in step 7.3. 50 µL of HRP solution 5 U/mL (0.25 U) are then added into each well as in step 7.5. Samples are incubated for 30 min at 37 °C as in step 7.6. 50 µL of fluorochrome reagent are then added into each well as in step 7.7 (final concentration of 300 µM). The fluorescent readout (in dark) is then assessed every minute over 120 minutes at 37 °C with a fluorescent plate reader (530/590 nm filters). Representative fluorescence data .......

Access restricted. Please log in or start a trial to view this content.

Discussion

The protocol described here offers a robust tool to answer important research questions regarding the role of HDL function in atherosclerosis and human disease. The assay quantifies the HDL lipid peroxide content per mg of HDL-C using enzymatic amplification (HRP). This approach avoids known limitations of prior HDL function assays (e.g. the cholesterol efflux assay) including significant heterogeneity with regards to types of cells used, type of readout reported, lack of standardization and confounding effects of trigly.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

This protocol and assay are relevant to the patent PCT/US2015/018147.

Acknowledgements

The authors gratefully acknowledge the work of Dr Mohamad Navab, Alan Fogelman and Srinivasa Reddy for their key role in development of earlier iterations of this model. T.A.A. is supported by an RMIT University Vice-Chancellor's Postdoctoral Fellowship. AJ and AH are supported by NHMRC project grant 1108792. TK is supported by NIH grants NIH K08AI08272, NIH/NCATS Grant # µL1TR000124.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Experimental Reagents
HDL PEG (Polyethylene Glycol) Precipitating ReagentPointe ScientificH7511
Amplex Red reagent.Life Technologies, Grand Island, NYA12216Amplex Red Cholesterol Assay Kit.
• ≤–20°C • Desiccate
• Protect from light
DMSO.Life Technologies, Grand Island, NYA12216Amplex Red Cholesterol Assay Kit.
• ≤–20°C • Desiccate
• Protect from light
Horse Radish Peroxidase (HRP)Life Technologies, Grand Island, NYA12216Amplex Red Cholesterol Assay Kit.
• ≤–20°C • Desiccate
• Protect from light
Cholesterol Esterase.Life Technologies, Grand Island, NYA12216Amplex Red Cholesterol Assay Kit.
• ≤–20°C • Desiccate
• Protect from light
Cholesterol Reference standardLife Technologies, Grand Island, NYA12216Amplex Red Cholesterol Assay Kit.
• ≤–20°C • Desiccate
• Protect from light
Resorufin fluorescense Reference standardLife Technologies, Grand Island, NYA12216Amplex Red Cholesterol Assay Kit.
• ≤–20°C • Desiccate
• Protect from light
5x Reaction Buffer.Life Technologies, Grand Island, NYA12216Amplex Red Cholesterol Assay Kit.
• ≤–20°C • Desiccate
• Protect from light
HDL Cholesterol Automated ReagentThermoFisher Scientific Co., San Jose, CA, USA.TR39601
NameCompanyCatalog NumberComments
Plasticware
96-well plates (polypropylene, flat bottom, clear).Sigma AldrichM0687
96-well plates (polypropylene, flat bottom, black).Sigma AldrichM9936
1.5 mL Eppendorf tubesEppendorf0030 125.150
ClipTip 200, sterileThermoFisher Scientific Co., San Jose, CA, USA.14-488-058
Thermo Scientific Multichannel Pipettes, 8-channel, 125 ThermoFisher Scientific Co., San Jose, CA, USA. 14-387--955
NameCompanyCatalog NumberComments
Software
Gen5 2.01 softwareBiotek, Vermont, USANA
NameCompanyCatalog NumberComments
Equipment
Gen5 Plate readerBiotek, Vermont, USANA

References

  1. Gordon, D. J., Rifkind, B. M. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med. 321, 1311-1316 (1989).
  2. Rubins, H. B., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Lipid Peroxidation AssayCell free Biochemical AssayFluorometric Enzymatic MethodHorseradish PeroxidaseAmplex Red ReagentFluorescent Plate ReaderHDL Lipid Peroxide ContentHDL Function MeasurementHDL Oxidation Analysis